Figure 1 (Avtozma 01)
Not available.*
Avtozma Injection, Solution
Product Images NDC 72606-044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Avtozma (NDC 72606-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Avtozma 02)
Figure A (Avtozma 03)
This text appears to be a description of components or parts of a medical device or syringe. It includes elements such as a plunger rod, finger flange, medicine window, needle guard, and a cap. It seems to be an instruction or guide showing the arrangement or order of these parts before and after use.*
Figure B (Avtozma 04)
This text describes the contents of a carton which includes a prefilled syringe, cotton ball or gauze with an alcohol swab, an adhesive bandage, and an FDA-cleared sharps disposal container. It seems to be a medical or first aid kit.*
Figure C (Avtozma 05)
Figure D (Avtozma 06)
Figure E (Avtozma 07)
Figure F (Avtozma 08)
Figure G (Avtozma 09)
Figure H (Avtozma 10)
Figure I (Avtozma 11)
Figure J (Avtozma 12)
Figure K (Avtozma 13)
Figure L (Avtozma 14)
Figure M (Avtozma 15)
Figure N (Avtozma 16)
Figure A (Avtozma 17)
This text provides instructions for a medical device, likely a syringe or injection kit, with details on actions to be taken before and after use. It mentions the expiration date, a body date, an orange indicator, a window for injection, and the components like a blue needle cover and an orange needle cover. The mention of a locked needle inside also indicates safety features of the device.*
Figure B (Avtozma 18)
This text provides a description of the contents of a carton. It includes cotton balls, an auto-injector, gauze, alcohol swabs, adhesive bandages, and a Sharps disposal container. These items are likely part of a first aid or medical kit.*
Figure C (Avtozma 19)
Figure D (Avtozma 20)
Figure E (Avtozma 21)
Figure F (Avtozma 22)
Figure G (Avtozma 23)
Figure H (Avtozma 24)
This text outlines the different options for administering medication, including self-injection as well as the involvement of caregivers and healthcare providers (HCP). It emphasizes the roles of caregivers and HCP in the administration process.*
Figure I (Avtozma 25)
Figure J (Avtozma 26)
Figure K (Avtozma 27)
Figure L (Avtozma 28)
Figure M (Avtozma 29)
Figure N (Avtozma 30)
Figure O (Avtozma 31)
Principal Display Panel (80 mg/4 mL Vial Carton)
The text provided is a detailed description of Avtozma, a medication with the active ingredient tocilizumab-anoh. It is an injection containing 80 mg per 4 mL (20 mg/mL) for intravenous infusion after dilution. The medication is in single-dose vials, and any unused portion should be discarded. The product should be stored refrigerated at 2-5°C and protected from light, without freezing or shaking. The dosage information should be obtained from prescribing information.*
Principal Display Panel (200 mg/10 mL Vial Carton)
Principal Display Panel (400 mg/20 mL Vial Carton)
This text provides information on a medication called Avtozma, specifically detailing the dosage, administration, and storage instructions for the injection. Avtozma contains tocilizumab-anoh and is intended for intravenous infusion after dilution. The medication is available in a 400 mg/20 mL strength, with a single-dose vial packaging. It emphasizes the importance of discarding any unused portion and mentions storage requirements. The text also includes pharmacode details and a reference to the product's identification numbers.*
Principal Display Panel (162 mg/0.9 mL Prefilled Syringe Carton)
Principal Display Panel (162 mg/0.9 mL Prefilled Syringe Carton)
This is information about the medication Avtozma containing tocilizumab-anoh in an injection form, with a dosage of 162 mg/0.9 mL for subcutaneous use only. The medication guide should be dispensed to each patient. The prefilled syringes come with a safety guard for ease of use.*
Principal Display Panel (4 Prefilled Syringe Carton)
This text provides information about single-dose prefilled syringes with a safety guard for subcutaneous use only. The syringe contains a medication called Avtozma (tocilizumab-anoh) at a concentration of 162 mg/0.9 mL. It is advised to dispense the enclosed Medication Guide to each patient. The medication does not contain preservatives and is manufactured by CELLTRION. The text also includes details about the manufacturer's location and distribution in the USA.*
Rincipal Display Panel (12 Prefilled Syringe Carton)
Reonly Avtozma is a medication available in injection form with a concentration of 162 mg/0.9 mL intended for subcutaneous use only. The product comes in a multipack containing three cartons, with each carton containing four 0.9-mL single-dose prefilled syringes with a safety guard. Additionally, each multipack includes a Medication Guide, Prescribing Information, and Instructions for Use. The National Drug Code for this product is 72606-045-03.*
Principal Display Panel (162 mg/0.9 mL Autoinjector Carton)
Principal Display Panel (162 mg/0.9 mL Autoinjectors Carton)
The text describes a medication that comes in single-dose autoinjectors for subcutaneous use only. It includes ingredients such as risperidone, listine hydrochloride, and meticrine. The medication does not contain preservatives. The text also mentions a medication guide that should be dispensed to each patient. The medication is manufactured by Celltrion, and the text provides information on dosage and distribution.*
Principal Display Panel (4 Autoinjectors Carton)
This is a product description for a single-dose autoinjector intended for subcutaneous use. The product contains etanercept as an active ingredient. It is manufactured by CELLTRION and distributed by CELLTRION USA. The package does not contain preservatives. The autoinjector is filled with 162 mg/0.9 ml solution. It is essential to dispense the enclosed Medication Guide to each patient.*
Principal Display Panel (12 Autoinjectors Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
